Interaction between ferroptosis and TNF ‐α: Impact in obesity‐related osteoporosis
The FASEB Journal · 2023
DOI: 10.1096/fj.202201958r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Xin Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Ferroptosis, Osteoporosis. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The relationship of obesity and osteoporosis has been widely studied over the past years. However, the implications of obesity for bone health remain controversial, and the underlying molecular mechanism is not yet fully understood. This study demonstrated that high‐fat diet‐induced obesity leads to significantly decreased bone volume/tissue volume (BV/TV), trabecular number (Tb.N), and cortical thickness (Ct.Th) of male rat femur after mechanical loading effects of body weight were controlled. HFD‐induced obese rats exhibited attenuated expression of ferroptosis inhibitory protein SLC7A11 and GPX4 in bone tissues, which was correlated with elevated serum TNF‐α concentration. Ferroptosis inhibitor administration could effectively rescue decreased osteogenesis‐associated type H vessels and osteoprogenitors, and downregulate serum levels of TNF‐α to ameliorate bone loss in obese rats. Since ferroptosis and TNF‐α both affect bone and vessel formation, we further investigated the interaction between ferroptosis and TNF‐α, and its impact in osteogenesis and angiogenesis in vitro. In human osteoblast‐like MG63 and umbilical vein endothelial cells (HUVEC), TNF‐α/TNFR2 signaling promoted cystine uptake and GSH biosynthesis to provide protection against low‐dose ferroptosis inducer erastin. While, TNF‐α/TNFR1 facilitated ferroptosis in the presence of high‐dose erastin through ROS accumulation. Moreover, TNF‐α regulated ferroptosis‐induced osteogenic and angiogenic dysfunctions based on its ferroptosis regulatory role. Meanwhile, ferroptosis inhibitors could reduce intracellular ROS overproduction and enhance osteogenesis and angiogenesis in TNF‐α‐treated MG63 and HUVECs. This study revealed the interaction between ferroptosis and TNF‐α and its impact in osteogenesis and angiogenesis, which provides new insights into the pathogenesis and regenerative therapy of obesity‐related osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, China.
- Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, China.
- Stomatological Hospital, Southern Medical University, Guangzhou, China.
ORCID-Profile: Chao Liu
Zitieren
APA
Chen, X., Liu, C., Yu, R., Gan, Z., Zhang, Z., Chen, Z., Liu, Y., Wu, D., Yu, X., Liu, C., & Cao, Y. (2023). Interaction between ferroptosis and TNF ‐α: Impact in obesity‐related osteoporosis. The FASEB Journal. https://doi.org/10.1096/fj.202201958r
Vancouver
Chen X, Liu C, Yu R, Gan Z, Zhang Z, Chen Z, et al. Interaction between ferroptosis and TNF ‐α: Impact in obesity‐related osteoporosis. The FASEB Journal. 2023. doi:10.1096/fj.202201958r
BibTeX
@article{Chen2023,
author = {Chen, Xin and Liu, Chao and Yu, Rongcheng and Gan, Ziqi and Zhang, Zhen and Chen, Zhengyuan and Liu, Yuanbo and Wu, Dongle and Yu, Xinyi and Liu, Chufeng and Cao, Yang},
title = {Interaction between ferroptosis and TNF ‐α: Impact in obesity‐related osteoporosis},
journal = {The FASEB Journal},
year = {2023},
doi = {10.1096/fj.202201958r}
}
EUVIMED